Predictive Value of Anti-Ro Antibody Positivity for Anti-AQP4 Autoantibody Test Results in Patients with Demyelinating Disease of Central Nervous System

Predictive Value of Anti-Ro Antibody Positivity for Anti-AQP4 Autoantibody Test Results in Patients with Demyelinating Disease of Central Nervous System

Dades bibliogràfiques
Autors principals:	Kim, J, Kim, S, Waters, P, Vincent, A, Park, K, Sung, J, Lee, K
Format:	Conference item
Publicat:	2012

Ítems similars

Neuromyelitis optic with positive Anti-AQP4 and Anti-SSA/Ro antibody
per: Riwanti Estiasari, et al.
Publicat: (2019-03-01)

Aquaporin-4 antibodies in Korean patients with idiopathic inflammatory demyelinating diseases of the central nervous system
per: Yang, H, et al.
Publicat: (2012)

Aquaporin-4 antibodies in Korean patients with idiopathic inflammatory demyelinating diseases of the central nervous system
per: Kim, J, et al.
Publicat: (2013)

Cell-based assay for anti-AQP4 antibody in Korean patients with neuromyelitis optica
per: Kim, B, et al.
Publicat: (2010)

Defining distinct features of anti-MOG antibody associated central nervous system demyelination
per: Martin S. Weber, et al.
Publicat: (2018-03-01)

Aquaporin-4 antibodies in Korean patients with idiopathic inflammatory demyelinating diseases of the central nervous system
per: Park, K, et al.
Publicat: (2012)

Clinical spectrum of demyelinating disease of central nervous system and frequency of anti AQP4 and anti MOG among them: one-year single-center retrospective study
per: Heena Faldu, et al.
Publicat: (2024-08-01)

Characterization of the spectrum of Korean inflammatory demyelinating diseases according to the diagnostic criteria and AQP4-Ab status.
per: Kim, S, et al.
Publicat: (2014)

Dissociating Autoantibody Responses against Ro52 Antigen in Patients with Anti-Synthetase or Anti-MDA5 Antibodies
per: Akira Yoshida, et al.
Publicat: (2023-12-01)

Clinical features associated with the presence of anti-Ro52 and anti-Ro60 antibodies in Jo-1 antibody-positive anti-synthetase syndrome
per: Koichi Yamaguchi, et al.
Publicat: (2024-06-01)

Serum Peptide Immunoglobulin G Autoantibody Response in Patients with Different Central Nervous System Inflammatory Demyelinating Disorders
per: Hye Lim Lee, et al.
Publicat: (2021-07-01)

Anti-MOG autoantibodies pathogenicity in children and macaques demyelinating diseases
per: Che Serguera, et al.
Publicat: (2019-11-01)

Reversible Conduction Failure in Anti-lactosylceramide-antibody-positive Combined Central and Peripheral Demyelination
per: Masaya Harada, et al.
Publicat: (2019-06-01)

Anti-IL-6 therapies in central nervous system inflammatory demyelinating diseases
per: Li Jiao, et al.
Publicat: (2022-10-01)

Optic Nerve Demyelination in IgG4 Anti–Neurofascin 155 Antibody–Positive Combined Central and Peripheral Demyelination Syndrome
per: Alice Verghese, et al.
Publicat: (2021-12-01)

Auto antibodies in inflammatory demyelinating diseases of the central nervous system
per: Swiss Medical Weekly
Publicat: (2008-11-01)

Sjögren’s syndrome positive for isolated anti-Ro52/SS-A antibody and anti-centromere antibody
per: Hideki Nakamura, et al.
Publicat: (2024-11-01)

Anti-Ro Antibody and Its Significance
per: Chaicharoen Tantanate
Publicat: (2006-02-01)

Anti-AQP4 autoantibodies promote ATP release from astrocytes and induce mechanical pain in rats
per: Teruyuki Ishikura, et al.
Publicat: (2021-08-01)

Clinical characteristics of anti-SRP antibody positive immune-mediated necrotizing myopathy with anti-TRIM21/Ro52 antibody positive
per: XU Li, GAO Huajie, YANG Mengge, LI Yue, JI Suqiong
Publicat: (2023-06-01)

Anti-Neurofascin 155 Antibody-Positive Chronic Inflammatory Demyelinating Polyneuropathy/Combined Central and Peripheral Demyelination: Strategies for Diagnosis and Treatment Based on the Disease Mechanism
per: Jun-ichi Kira, et al.
Publicat: (2021-06-01)

Strategies to Screen Anti-AQP4 Antibodies from Yeast Surface Display Libraries
per: Huang, Aric, et al.
Publicat: (2022)

Strategies to Screen Anti-AQP4 Antibodies from Yeast Surface Display Libraries
per: Aric Huang, et al.
Publicat: (2022-06-01)

RELAPSING AQP4 ANTIBODY NEGATIVE NMO WITH MOG ANTIBODIES
per: Elsone, L, et al.
Publicat: (2014)

Anti-aquaporin 4 antibody-positivity of Korean patients with neuromyelitis optica spectrum disorders
per: Min, J, et al.
Publicat: (2010)

Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders.
per: Sato, D, et al.
Publicat: (2014)

Transverse Myelitis Associated with Anti-Ro (SSA) Autoantibodies: A Record of Two Cases
per: G. Melikyan, et al.
Publicat: (2012-01-01)

Serial anti–myelin oligodendrocyte glycoprotein antibody analyses and outcomes in children with demyelinating syndromes
per: Waters, P, et al.
Publicat: (2019)

Autoantibodies at the neuromuscular junction - Link to the central nervous system
per: Vincent, A
Publicat: (2014)

Sicca syndrome in the same family – the importance of anti-Ro60, anti-Ro52 and anti-La antibody profiling in Sjögren’s syndrome
per: Arkadiusz Koszarny, et al.
Publicat: (2021-08-01)

Psychiatric disorders in children with demyelinating diseases of the central nervous system
per: Pakpoor, J, et al.
Publicat: (2017)

Macrophages and Autoantibodies in Demyelinating Diseases
per: Haruki Koike, et al.
Publicat: (2021-04-01)

Anti-Ro Positivity in Systemic Lupus Erythematosus: Association with Clinical Phenotypes and Other Antibodies
per: Anum Khan, et al.
Publicat: (2024-01-01)

Anti-Ro and anti-La autoantibodies induce TNF-α production by human salivary gland cells: an in vitro study
per: V. Mitolo, et al.
Publicat: (2011-09-01)

Demyelinating Disease? Central Nervous System Lymphoma?
per: Ufuk Ergün, et al.
Publicat: (2008-06-01)

New autoantibody mediated disorders of the central nervous system.
per: Lang, B, et al.
Publicat: (2003)

Anti-TNFa treatment in patients with rheumatoid arthritis and anti-Ro/SSA antibodies
per: P. Airò, et al.
Publicat: (2011-09-01)

Olfactory Pathology in Central Nervous System Demyelinating Diseases.
per: DeLuca, G, et al.
Publicat: (2014)

Peripheral nervous system involvement in MOG antibody-associated demyelination
per: Ramanathan, S, et al.
Publicat: (2019)

Efficacy for the Annual Relapse Rate after the Immunosuppressive Therapy in Patients Associated with Anti-AQP4 or Anti-MOG Antibody-Positive Optic Neuritis
per: Sotaro Mori, et al.
Publicat: (2020-01-01)